Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum Levels of MicroRNA-371a-3p for Predicting the Histology of Postchemotherapy Residual Masses of Germ Cell Tumours

9 May 2024

Abstract excerpt

BACKGROUND AND OBJECTIVE: Serum levels of microRNA-371a-3p (M371) represent a novel and sensitive biomarker of germ cell tumours (GCTs). This study analysed the utility of M371 to identify viable cancer (VC) in postchemotherapy (pc) residual masses with the underlying goal of avoiding overtreatment. METHODS: A multicentric, prospective diagnostic study was conducted in 180 GCT patients undergoing pc resection of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ovarian cancer diagnosis and treatment
Share to Sperm and Testicular Function
Share to Testicular diseases and treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38729824
DOI: 10.1016/j.euf.2024.05.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum Levels of MicroRNA-371a-3p for Predicting the Histology of Postchemotherapy Residual Masses of Germ Cell TumoursPMID 38729824Read ↗

Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell TumoursSemantic proximity Read ↗

Current and Evolving Biomarkers in the Diagnosis and Management of Testicular Germ Cell TumorsSemantic proximity Read ↗

MicroRNA-371a-3p—The Novel Serum Biomarker in Testicular Germ Cell TumorsSemantic proximity Read ↗

Clinical utility of plasma miR‐371a‐3p in germ cell tumorsSemantic proximity Read ↗

Germ cell tumour subtypes display differential expression of microRNA371a-3pSemantic proximity Read ↗

Improving outcomes in germ cell cancers using miRNASemantic proximity Read ↗

Refining the serum miR-371a-3p test for viable germ cell tumor detection: identification and definition of an indeterminate rangeSemantic proximity Read ↗

The Role of miRNA in Testicular Cancer: Current Insights and Future PerspectivesSemantic proximity Read ↗

Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell CancerSemantic proximity Read ↗

MicroRNA-profiling of miR-371~373- and miR-302/367-clusters in Serum and Cerebrospinal Fluid Identify Patients with Intracranial Germ Cell TumorsSemantic proximity Read ↗

Decoding testicular germ cell tumors: integrating risk, biology, and biomarkers into future care.Semantic proximity Read ↗

MicroRNA ‐371–373 cluster and methylome analysis suggests that a subset of ‘somatic‐type’ malignancies arising in germ cell tumors may originate in yolk sac tumor componentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.